The landscape of biomedical research has experienced a remarkable expansion in recent years, driven heavily by advances in peptide chemistry and targeted receptor pharmacology. Among the diverse array of synthetic peptide analogs investigated by laboratories worldwide, PT-141—commonly recognized in scientific literature as bremelanotide—occupies a unique position of interest. Researchers examining melanocortin signaling pathways frequently seek […]